Healthcare -
Biotechnology - NASDAQ - US
$ 21.7
2.12 %
$ 238 M
Market Cap
-0.91
P/E
CDTX - TOTAL RECEIVABLES
Total Receivables CDTX - Cidara Therapeutics, Inc.
16.2 M
LAST VALUE
74.16%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR